Close Menu

NEW YORK – Predictive Oncology said Friday that it has reached agreements with investors for a direct offering of more than 3.4 million shares at $1.20 per share, for gross proceeds of approximately $4.1 million.

The firm also has agreed to issue investors slightly more than 1.7 million warrants at $1.37 per share. These warrants will expire 5.5 years from issuance.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.